International Star Inc. Appoints Todd Masse as New CEO

$ACB
Medicinal Chemicals and Botanical Products
Health Care
Get the next $ACB alert in real time by email

DOVER, DE / ACCESSWIRE / April 10, 2024 / International Star, Inc. (OTC:ILST) (the "Company" or "ILST") is pleased to announce the appointment of Todd Masse as its new Chief Executive Officer effective April 3, 2024. Mr. Masse has over 25 years of extensive experience managing and operating businesses across various industries, including startups, consumer-packaged goods, technology, and real estate.

Since 2015, Mr. Masse has been a key figure in the cannabis industry, serving as both an entrepreneur and operator. His visionary leadership and innovative approach have driven growth and success in this rapidly evolving sector.

Mr. Masse's achievements include serving as President of Cannabis Compliance Inc., leading the company to become a frontrunner in compliance solutions. Under his leadership, the company was acquired by Deloitte.

Additionally, as Chief Commercial Officer (CCO) of Thrive Cannabis, Mr. Masse successfully introduced the Greybeard cannabis brand, pioneering Canada's first BHO and Live Resin products. His efforts significantly contributed to the company's acquisition by Aurora Cannabis Inc. (NASDAQ:ACB)(TSX:ACB) for thirty-eight million dollars ($38,000,000).

"We are thrilled to welcome Todd Masse as our new CEO," said former interim CEO Nochum Greenberg. "His track record of success and deep industry knowledge make him the ideal leader to drive our company forward. We are confident that International Star will continue to grow and thrive under his guidance."

Mr. Masse stated: "I am honored and excited to join ILST at such a pivotal moment in the cannabis industry. The potential for growth and impact in this industry is immense, and I am eager to work alongside our talented team to drive forward our mission of delivering high-quality products and experiences to our customers while advancing the industry. I'm looking forward to connecting with shareholders and outlining my vision and plans in an upcoming letter to investors.

About International Star Inc:
International Star Inc. (OTC:ILST) operates through its wholly-owned subsidiary, Budding Equity Inc. ("BEi") and its 20% ownership stake in B Studios LLC. BEi owns and licenses intellectual property through contracts with movie studios and celebrities and structures licensing deals with third parties for cannabis-related products. The company also maintains joint ventures with affiliates of Ice Cube and Kevin Smith to license and brand cannabis and cannabis-related products. B Studios focuses on producing cannabis-themed films and capitalizing on product placement and licensing. A core focus of ILST remains acquiring and developing innovative businesses with high growth potential in the cannabis space and beyond. For more information, you can visit our website at www.ilstinc.com.

For media inquiries, please contact: mailto:Investors@ilstinc.com

Contact Information:
International Star, Inc.
8 The Green
Suite 16020
Dover, DE 19901
Website: www.ilstinc.com

Forward-Looking Statements:
This press release contains "forward-looking statements." Words such as "may," "should," "will," "could," "would," "predicts," "potential," "continue," "expects," "anticipates," "confident," "future," "intends," "plans," "believes," "estimates," and similar expressions, as well as statements in the future tense, often signify forward-looking statements. These forward-looking statements are, by their nature, subject to significant risks and uncertainties.

Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information that the Company has when those statements are made or management's good faith belief as of that time concerning future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements, including factors beyond the Company's control. As a result of these and other risks, uncertainties, and assumptions, forward-looking events and circumstances discussed herein might not occur in the way the Company expects or at all. Accordingly, readers should not place reliance on any forward-looking information or statements. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events, or otherwise. All forward-looking statements herein are qualified by reference to the cautionary statements outlined in this section.

SOURCE: International Star, Inc.



View the original press release on accesswire.com

Get the next $ACB alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ACB

DatePrice TargetRatingAnalyst
12/11/2024Buy
TD Cowen
2/9/2024Hold → Buy
Canaccord Genuity
9/21/2022Sell → Hold
Canaccord Genuity
6/24/2022Neutral → Overweight
Cantor Fitzgerald
6/6/2022Sell → Hold
Stifel
11/10/2021$9.60 → $10.75Neutral
Cantor Fitzgerald
10/28/2021$9.50 → $9.60Neutral
Cantor Fitzgerald
10/5/2021$8.30 → $9.50Neutral
Cantor Fitzgerald
More analyst ratings

$ACB
Press Releases

Fastest customizable press release news feed in the world

See more
  • Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail

    Canada's Largest Medical Cannabis Company is an Honouree in The Globe and Mail's 2025 Report on Business Magazine's sixth annual Women Lead Here List EDMONTON, AB, March 31, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, has been named an honouree on the Globe & Mail's 2025 Report on Business, Women Lead Here list. This annual editorial benchmark recognizes the top publicly traded Canadian companies with the highest gender diversity at the executive level. "As a company with a leading purpose of bein

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit

    NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company to Participate as an Industry Leader in the Inaugural Regulatory Event in Washington, D.C. EDMONTON, AB, March 25, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to be attending, sponsoring and speaking at the 2025 Global Cannabis Regulatory Summit (GCRS), held within the U.S. Capitol Complex in Washington, D.C. on March 26-27, 2025. "The opportunity to speak on this global stage, underscores our position as industry leaders and d

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars

    NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial launc

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

$ACB
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$ACB
SEC Filings

See more

$ACB
Leadership Updates

Live Leadership Updates

See more
  • Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

    NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB, Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately. Mr. Martin has served as Chief Executiv

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting

    NASDAQ | TSX: ACB EDMONTON, AB, Aug. 12, 2024 /PRNewswire/ -  Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date. All of

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis Announces Appointment of New Director

     NASDAQ | TSX: ACB  Newly created directorship to be filled by Rajesh Uttamchandani EDMONTON, AB, May 15, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today the appointment of Rajesh Uttamchandani to the Company's Board of Directors (the "Board"), effective today. Mr. Uttamchandani joins the Board with notable expertise in strategy development, innovation, human capital and governance. His impressive career is characterized by executive level roles with leadin

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

$ACB
Financials

Live finance-specific insights

See more
  • Aurora Cannabis Announces Fiscal 2025 Third Quarter Results

    NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoYGenerates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoYAchieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third qu

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call

    NASDAQ | TSX: ACB EDMONTON, AB, Jan. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 5, 2025 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer,

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis Announces Fiscal 2025 Second Quarter Results

    NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210%Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical CannabisRe-Affirms Target of Positive Free Cash Flow1 in the Quarter Ending December 31, 2024Maintains Strong Balance Sheet with ~$152 Million of Cash and a Debt-Free Cannabis Business2EDMONTON, AB, Nov. 6, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter fiscal 2025.

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

$ACB
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more